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In vitro metabolomic footprint of 
the Echinococcus multilocularis 
metacestode
Dominic Ritler1, Reto Rufener1, Jia V. Li2, Urs Kämpfer3, Joachim Müller1, claudia Bühr3, 
Stefan Schürch3 & Britta Lundström-Stadelmann1*
Alveolar echinococcosis (Ae) is a zoonotic disease that is deadly if left untreated. Ae is caused by the larval 
metacestode stage of the cestode Echinococcus multilocularis. Better knowledge on the host-parasite 
interface could yield novel targets for improvement of the treatment against Ae. We analyzed culture 
media incubated with in vitro grown E. multilocularis metacestodes by 1H nuclear magnetic resonance 
spectroscopy to identify the unknown metabolic footprint of the parasite. Moreover, we quantitatively 
analyzed all amino acids, acetate, glucose, lactate, and succinate in time-course experiments using liquid 
chromatography and enzymatic assays. the E. multilocularis metacestodes consumed glucose and, 
surprisingly, threonine and produced succinate, acetate, and alanine as major fermentation products. 
The metabolic composition of vesicle fluid (VF) from in vitro grown E. multilocularis metacestodes was 
different from parasite-incubated culture medium with respect to the abundance, but not the spectrum, 
of metabolites, and some metabolites, in particular amino acids, accumulated in the Vf. overall, this study 
presents the first characterization of the in vitro metabolic footprint of E. multilocularis metacestodes and 
Vf composition, and it provides the basis for analyses of potentially targetable pathways for future drug 
development.
Platyhelminths (flatworms), including cestodes (tapeworms) and trematodes (flukes) cause a variety of human 
and animal infections. Currently, the highest ranked foodborne parasite in Europe is Echinococcus multilocularis, 
the small fox tapeworm1. Infection with this cestode causes the disease alveolar echinococcosis (AE) in humans. 
E. multilocularis is endemic to the Northern hemisphere including areas in Europe, Asia, and North America2. 
Over the recent years, E. multilocularis has been emerging in Europe, North America and Asia3–5. The life cycle 
of E. multilocularis includes canids as definitive hosts, and voles as intermediate hosts. Humans, and other mam-
mals such as dogs, captive monkeys, and beavers, can be infected as accidental intermediate hosts by ingesting 
parasite eggs shed within the feces of definitive hosts. Thereby, these accidental hosts can acquire the disease AE. 
In humans, E. multilocularis grows as larval metacestodes, which primarily affect the liver and cause the disease 
AE, but they can also form metastases in other organs, especially at the late stage of infection6. Human AE is a 
chronic disease with extensive morbidity and mortality if remained untreated. Curative treatment is based on 
radical surgical resection in combination with temporal chemotherapy, applied in 20 to 50% of all cases6. Lifelong 
chemotherapeutical treatment based on benzimidazole-carbamate derivatives is applied if radical surgery is not 
possible. This treatment, however, may fail, and has a limited potential for complete cure. In addition, it can 
induce severe, life-threatening side-effects7. With increasing numbers of patients and no alternative to benzimi-
dazoles developed so far, new and better treatment options are urgently needed8.
Morphologically, metacestodes are multivesicular larval stages surrounded by an acellular, carbohydrate-rich 
laminated layer8. Inside the vesicles, the parasite tissue is comprised of the cellular germinal layer, which covers 
the inner surface of the laminated layer. The germinal layer consists of muscle cells, nerve cells, glycogen storage 
cells, connective tissue, and undifferentiated stem cells9,10. The syncytial tegument, as the most outer part of the 
germinal layer, constitutes the interface between the germinal and the laminated layer, and it forms microtriches 
protruding from the germinal layer into the laminated layer11. Release of small vesicles from these microtriches 
has been described, which could be involved in release or uptake of metabolites12.
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Metabolomics provides an excellent tool to characterize host-parasite interactions13–15. Metabolites such as amino 
acids, lipids, or sugars directly reflect the biochemical activity and the metabolic state of cells or tissues16,17. Various 
studies applied metabolic profiling to study diseases caused by flatworms in vivo, namely Echinostoma caproni 
in mice18,19, Fasciola hepatica in rats20, Onchocerca volvulus in humans21, Opisthorchis felineus in hamsters22  
and humans23, and Schistosoma mansoni in mice24–26 and humans27. Only few studies directly assessed the met-
abolic composition of flatworms like S. mansoni28 and F. hepatica29. Cestodes were largely neglected in modern 
metabolomic studies, and no in-depth analyses have been performed to investigate the metabolic behavior of flat-
worms or the metabolic relationship between hosts and flatworms. Such metabolic information, however, could 
promote the development of therapeutic treatments, for example by blocking the nutrient uptake by the parasites. 
1H Nuclear magnetic resonance (NMR) provides a, highly reproducible tool for untargeted footprinting of known 
and especially unknown metabolites with minimal interference due to sample preparation. Mass spectrometry 
(MS) is frequently used in metabolomics as well, and it is more sensitive than NMR. However, MS has a lower 
reproducibility and requires targeted pre-processing of samples, which narrows down the group of metabolites 
identified. Thus, NMR is the method of choice for untargeted metabolomic footprinting30. The metabolism of E. 
multilocularis is of particular interest, as genomic and transcriptomic analyses revealed that the parasite is defi-
cient in large parts of amino acid, nucleotide and lipid synthesis, but has developed several protein families for 
nutrient uptake31–33.
E. multilocularis metacestode vesicles are filled with vesicle fluid (VF), which contains parasite and host com-
ponents, and it is assumed to be involved in nutrition storage. The analogous hydatid fluid of E. granulosus, a 
close relative to E. multilocularis, contains pools of amino acids, sugars, lipids, fermentation end products such 
as acetate, alanine, lactate, and succinate, in metacestodes harvested from naturally infected intermediate hosts 
or human patients34–39, or from experimentally infected mice40,41. In vitro uptake of cholesterol into E. granulosus 
cysts has been demonstrated by the use of radiolabeled lipids42. One earlier study addressed changes in metabolite 
composition of E. multilocularis VF in vitro upon drug treatment, identifying four major fermentation end prod-
ucts, namely acetate, alanine, lactate, and succinate43. In another study, the metabolites of E. multilocularis cysts 
grown in treated versus non-treated animals were compared, and most pronounced differences were found in the 
levels of acetate, alanine, glycerolphosphatidylcholine, glycine, glycogen, and succinate44. Thus far, no metabo-
lomic study has been performed applying the defined E. multilocularis metacestode in vitro culture system45,46, 
which allows for further molecular analyses of interesting pathways.
E. multilocularis protoscoleces use glucose as a major energy source, accumulate glycogen in vitro47 and 
express all enzymes of glycolysis, fermentation, and the tricarboxylic acid cycle48. Decreased glucose levels are 
detected in all organs of E. multilocularis infected jirds, and accordingly also reduced glycogen levels in the livers 
of these infected animals49. This further strengthens the importance of the energy source glucose also in an in vivo 
setting. The metabolic end products of glucose as an energy source of E. multilocularis protoscoleces are acetate, 
lactate, and succinate47. In contrast to protoscoleces, information on energy and intermediate metabolisms of 
the disease-causing stage of E. multilocularis, the metacestode, is scarce. Here, we present a study identifying the 
metabolites consumed and released by E. multilocularis metacestodes under anaerobic growth conditions using 
1H-NMR for the identification, and liquid chromatography as well as enzymatic assays for the subsequent quan-
tification of selected metabolites. Our study shows that metacestodes secrete acetate and succinate at the expense 
of glucose, and that threonine is the major amino acid consumed from the medium.
Methods
If not stated otherwise, all chemicals and materials were purchased from Sigma-Aldrich (Buchs, Switzerland). Cell 
culture media and fetal bovine serum were from Bioswisstec (Schaffhausen, Switzerland). Statistical analyses were 
performed using the software package R (V 3.4.1). Figure plotting was done with the R package ggplot2 (V 3.0.0) 
and figure layouts were finalized using Adobe Illustrator CC (V 22.0.1).
experimental design. To identify metabolic changes at the interface of the E. multilocularis metacestode 
with its growth medium, the in vitro setup depicted in Fig. 1 was applied. Reuber rat hepatoma cells (RH) were 
used to precondition culture medium for subsequent E. multilocularis metacestode vesicle incubation. This pre-
conditioned medium was incubated in vitro with E. multilocularis metacestode vesicles. The metabolites in the 
corresponding samples of parasite-interacted medium (vcDMEM) and control incubated medium (ccDMEM) 
were analyzed by NMR spectroscopy. Metacestode vesicle fluid (VF) was also analyzed. To verify the NMR results 
and get a quantitative time-course measurement of selected metabolites, the same in vitro interaction setup was 
repeated independently, and samples analyzed by enzymatic acetate, glucose, lactate, and succinate measurements, 
as well as by free amino acid quantification with HPLC for different timepoints.
Echinococcus multilocularis metacestode culture. Echinococcus multilocularis metacestodes vesicles 
(isolate H95) were cultured as described before50.
preparation of host cell conditioned medium. 107 RH feeder cells were seeded in a T175 cell culture 
bottle in 50 ml DMEM containing 10% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, and 5 μg/ml tetracycline, 
and incubated for one day at 37 °C, 5% CO2, humid atmosphere. Subsequently, RH cells were washed three times 
with PBS and 50 ml DMEM without phenol red. For the next four days, cells were incubated in 50 ml DMEM with-
out phenol red and 0.2% heat inactivated FBS at 37 °C in 5% CO2, humid atmosphere. This host cell conditioned 
medium (cDMEM) was sterile filtered and directly used for incubation with E. multilocularis metacestode vesicles.
Metabolite exchange between E. multilocularis metacestodes and host cell conditioned medium. 
To identify the metabolic footprint of E. multilocularis metacestodes, i.e. metabolites released or consumed by E. mul-
tilocularis metacestodes into or from the surrounding culture medium in vitro, the following setup was performed: 
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Metacestodes were cultured for 12 weeks to reach a metacestode vesicle size of 2 to 4 mm in diameter. Metacestode 
vesicles were purified with 2% sucrose and PBS, and washed once in cDMEM. Subsequently, metacestode vesicles 
were incubated at a ratio of 1:2 in cDMEM for 72 h at 37 °C in a closed tube, resulting in the E. multilocularis meta-
cestode vesicle interaction medium (vcDMEM). Integrity of metacestode vesicles was visually confirmed during the 
course of the experiment. Correspondingly, cDMEM only was incubated as control (ccDMEM) at 37 °C in a closed 
tube. For both media, ten biological replicates were analyzed. Medium supernatants were then stored at −80 °C for 
subsequent metabolite analysis. From the residual metacestodes, VF was extracted by washing the metacestodes 
3 x in PBS and breaking them with a 1 ml pipette tip. Metacestodes were centrifuged at 9’000 × g for 20 min, 4 °C. 
The supernatant (VF) was centrifuged at 12’000 × g for 20 min, 4 °C and stored at −80 °C for subsequent metabolite 
analysis. VF was analyzed in five biological replicates.
nMR sample preparation and data acquisition. Medium and VF samples from the above-described 
interaction were further prepared and analyzed by NMR at the Imperial College, London, UK. Details on sample 
preparation and data acquisition are found in Supplementary Methods 1.
Metabolite identification. Metabolites were identified using Chenomx NMR Suite (V 8.2; May-01-2016 
with Java 1.8.0_74 (x86)), Human Metabolite Database (HMDB)51, 2D NMR spectra and the published 2D NMR 
data51,52, and statistical total correlation spectroscopy (STOCSY) with the script IMPaCTS (v 1.0.0) in Matlab 
(V R2015b 8.6.0.267245)53.
Data processing and statistical analysis of nMR spectra. Spectra were digitized into 20,000 data 
points with a resolution of 0.0005 ppm and peak regions between δ1H -0.01 to 0.01 for TSP and δ1H 4.68 to 5.04 
for water were removed. Peaks were aligned using recursive segment-wise peak alignment (RSPA)54 and probabil-
istic quotient normalization was performed using IMPaCTS. To investigate changes in the relative concentrations 
Figure 1. Graphical representation of the experimental setup. The experimental setup for the metabolic foot 
printing of E. multilocularis metacestodes in vitro included (a) medium preconditioning with rat hepatoma 
cells for four days in DMEM including 0.2% FCS to enrich the medium with host cell metabolites (cDMEM). 
(b) incubation of cDMEM with in vitro cultured E. multilocularis metacestode vesicles (vcDMEM) or mock 
incubation for control (ccDMEM) over 72 h (for 1H NMR analysis) or for the time-points 0, 2, 6, 10, 24, 48, 72 h 
(for quantitative measurements). During this time, metacestode vesicles consumed and released metabolites 
(indicated by arrows). Samples of vcDMEM, ccDMEM, and vesicle fluid (VF) were harvested for subsequent 
metabolite identification by 1H NMR, HPLC, or enzymatic assays.
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of metabolites between the experimental groups, principal component analysis (PCA) and orthogonal projec-
tion to latent structure-discriminant analysis (OPLS-DA) were performed using the IMPaCTS script55,56. For 
OPLS-DA, the PLS and orthogonal components were calculated based on the mean-centered data scaled to 
unit variance. A seven-fold cross validation was used, and the corresponding cross-validation parameter was 
expressed as Q2Y. The total explained variation of the X matrix was indicated by the goodness of the fit (R2X). 
Figures were plotted as vector graphics in Matlab.
enzymatic assays for detection of acetate, glucose, lactate, and succinate. The levels of the metab-
olites acetate, glucose, lactate, and succinate were measured in the time-course samples (0, 2, 6, 10, 24, 48, 72 h) 
of vcDMEM and ccDMEM, as well as the endpoint sample VF (72 h) using the Acetate Colorimetric Assay Kit 
(MAK086, Sigma, USA), the Glucose-Glo TM Assay kit (J6021, Promega, USA), the Lactate-Glo TM Assay kit 
(J5021, Promega, USA), and the Succinic Acid Assay kit (K-SUCC, Megazyme, Germany) according to the man-
ufacturers’ protocols. Measurements were made on an EnSpire 2300 plate reader (PerkinElmer Life Sciences, 
Schwerzenbach, Switzerland). Acetate, glucose, lactate, and succinate concentrations were calculated by linear 
regression based on the standard (0.00 to 10.00 nmol for acetate, 4.39 to 50.00 mM for glucose, 0.20 to 50.00 mM for 
lactate, and 0.13 µg to 4.00 µg total succinate) after subtraction of the respective enzyme blanks. Biological triplicates 
were analyzed for each sample and median and range (min, max) were calculated to represent the measured values. 
Linear reduction/accumulation rates were calculated using linear regression analysis in R and expressed as concen-
tration changes in mM per hour.
Amino acid quantification. To analyze the free amino acid content in the time-course samples (0, 2, 6, 10, 
24, 48, 72 h) of vcDMEM and ccDMEM, the endpoint samples of VF (72 h), as well as germinal layer cell extracts 
of metacestodes at 72 h (for purification see Supplementary Methods 2), high-performance liquid chromatogra-
phy (HPLC) was performed as described in Supplementary Methods 3. Biological triplicates were analyzed for 
each sample. For each amino acid and timepoint, median and range were calculated to represent the measured 
values. For metabolites with a linear change over time, reduction/accumulation rates were calculated using lin-
ear regression analysis in R and expressed as concentration changes in mM per hour. Other metabolites were 
analyzed by polynomial regression analysis in R and expressed as half-maximal or half-minimal times in hours.
Amino acid frequencies in proteins of germinal layer cells (cell preparation and hydrolysis in Supplementary 
Methods 2) were analyzed by HPLC accordingly. The amino acid content of metacestode proteins was calculated 
by subtracting the free amino acids from the hydrolyzed amino acids of the germinal layer cell extracts.
To analyze the relationship between the consumption and the concentration of essential amino acids in VF, 
germinal layer cell extracts, and metacestode proteins, linear regression and Cook’s distance outlier analysis were 
performed in R. Consumption of essential amino acids by metacestodes was defined as the difference between the 
pool sizes in ccDMEM and vcDMEM.
comparative statistical analyses of metabolite measurements. Integral intensities of the selected 
peaks from each metabolite identified by 1D 1H NMR were calculated for vcDMEM, ccDMEM and VF samples 
in Matlab (V R2015b 8.6.0.267245) and compared with the metabolite concentrations measured by enzymatic 
assays for acetate, glucose, lactate, and succinate and by free amino acid quantification using t-distribution of 
Person’s product-moment correlation in R. Tow sample t-test (two-tailed) was performed between metabolites of 
vcDMEM and VF as measured by free amino acid quantification and enzymatic assays. P values were Bonferroni 
adjusted with a significance level of α = 0.05.
To determine the percentage of glucose used for production of acetate, alanine, lactate, and succinate, pyruvate 
equivalents were calculated from the concentrations derived from enzymatic assays and free amino acid quanti-
fication. Thereby percentages were calculated by setting the glucose pyruvate equivalent concentration to 100%.
Results
the metabolic footprint of the Echinococcus multilocularis metacestode in culture medium. 
Culture media containing E. multilocularis metacestode vesicles and control media (see Fig. 1) were analyzed 
using 1D 1H NMR spectroscopy to identify the metabolic footprint of E. multilocularis metacestodes in vitro. 
Representative 1D 1H NMR spectra are shown in Supplementary Fig. 1a,b. Multivariate statistical analyses includ-
ing PCA and OPLS-DA were performed on the 1H NMR spectral data to investigate the metabolic differences 
between vcDMEM and ccDMEM. Clear group separations between vcDMEM and ccDMEM were observed in 
the PCA scores plot along the first principal component with an explained variation (R2X) of 98.39% (Fig. 2a). 
OPLS-DA scores plot also showed a clear separation between the two groups with a total explained variance of 
R2X = 0.98 and the corresponding cross validation value Q2Y = 0.99, which indicates a high goodness of fit (R2X) 
and predictability (Q2Y) (Fig. 2b). Thus, substantial differences between vcDMEM and ccDMEM were detectable 
by 1H NMR, reflecting the parasite-induced changes in the culture media.
Upon metabolite annotation of the 1H NMR spectra of vcDMEM and ccDMEM, a total of 21 metabolites 
were identified (Table 1, Supplementary Fig. 1a,b). To identify differences in the metabolite levels between vcD-
MEM and ccDMEM, the PCA loadings plot and the OPLS-DA coefficient loadings plot were derived from 1D 
1H NMR spectra. The PCA loadings plot indicates that acetate, glucose, and succinate contribute most to the 
variation between vcDMEM and ccDMEM (Fig. 2c). Metabolites with a negative OPLS-DA discrimination score 
(Fig. 2d, Table 2), and thereby present at higher levels in ccDMEM than vcDMEM, i.e. being consumed by the 
parasite, were glucose, isoleucine, leucine, methionine, phenylalanine, threonine, tryptophan, tyrosine, and 
valine. Accordingly, several metabolites were released by the parasite with a positive OPLS-DA correlation coef-
ficient (Fig. 2d, Table 2), exhibiting higher levels in vcDMEM than ccDMEM: acetate, acetone, alanine, aspartate, 
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Figure 2. Multivariate statistical analysis of 1H NMR spectra. Multivariate comparison between vcDMEM 
(red, n = 10) and ccDMEM (blue, n = 10) acquired from 1D 1H NMR spectra after normalization. (a) Principal 
component analysis (PCA) scores plot of vcDMEM and ccDMEM. Groups are separated in the first principal 
component (PC1) with an explained variance of 98.39%. (b) Respective orthogonal projection to latent 
structure discriminant analysis (OPLS-DA) scores plot of vcDMEM and ccDMEM also clearly separated 
the two groups. Tcv depicts the inter-group variation, Tosc the intra-group variation. (c) Annotated PCA 
loadings plot of vcDMEM and ccDMEM. Annotated metabolites are indicated by various colors. (d) Annotated 
OPLS-DA coefficient plot of vcDMEM and ccDMEM. The x-axis depicts the chemical shifts in ppm. Peaks 
orientating upwards form the baseline show higher metabolite abundance in vcDMEM, from the baseline 
downwards pointing peaks show higher abundance in ccDMEM. The significance that each peak contributes 
to the difference between the two groups is indicated color-coded from blue low to red (scale on the right). The 
total explained variance (R2X) was 0.98 and the corresponding cross-validation (Q2Y) was 0.99. Amino acids are 
annotated using the three-letter code, for all other metabolites, full names are given.
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ethanol, formate, fumarate, glycine, lactate, lysine, malate, and succinate. Note that acetone, ethanol, lysine, phe-
nylalanine, tryptophan, and tyrosine showed only a low correlation coefficient.
The amino acid threonine was found exclusively in ccDMEM, and only baseline levels were found in vcD-
MEM (Table 2). The amino acids alanine and aspartate, and the dicarboxylic acids fumarate, malate, and suc-
cinate were identified in vcDMEM with baseline levels in ccDMEM (Table 2). All other identified metabolites 
(acetate, acetone, ethanol, formate, glucose, glycine, isoleucine, lactate, leucine, lysine, methionine, phenylala-
nine, tryptophan, tyrosine, and valine) were found in both vcDMEM and ccDMEM (Table 2).
Quantification of selected metabolites in culture media. To confirm the 1H-NMR results and to 
quantify selected metabolites, concentrations of acetate, glucose, lactate, and succinate, as well as all amino 
acids, were determined by enzymatic assays or HPLC. Moreover, the changes in metabolite composition were 
analyzed in time-course experiments. Hereby, five amino acids not detectable by NMR were identified, namely 
arginine, glutamate, histidine, proline and serine (Fig. 3). The correlation of the concentrations determined 
by 1H-NMR and by quantitative methods were highly significant for both the samples of ccDMEM (Pearson: 
r = 0.99, p = 2.20 * 10−16) and of vcDMEM (Pearson: r = 0.91, p = 2.84 * 10−6). Amongst all quantitatively meas-
ured metabolites, glucose showed the largest concentration reduction after 72 h of culture with a stable median 
concentration of 24.71 mM in ccDMEM and a linear reduction to 16.73 mM in vcDMEM (linear reduction 
rate = 0.10 mM glucose/hour, Fig. 3). Acetate had a stable median concentration of 0.64 mM in ccDMEM. In 
vcDMEM acetate accumulated over the first 10 h with a linear rate of 0.23 mM acetate/hour. Between 10 and 
72 h of in vitro culture, this rate dropped to 0.03 mM acetate/hour (Fig. 3). Lactate was at a concentration of 
3.01 mM in ccDMEM and 4.04 mM in vcDMEM, with an increase mostly during the first 10 h (Fig. 3). Succinate 
showed a stable median concentration of 0.19 mM in ccDMEM that increased to 9.01 mM in vcDMEM (linear 
accumulation rate = 0.13 mM/hour). Alanine was stable at 0.02 mM in ccDMEM, but reached 0.71 mM in vcD-
MEM, plateauing after 48 h (half-maximal concentration reached after 13.46 h). Aspartate, glutamate, and gly-
cine concentrations increased slightly over time in vcDMEM (Fig. 3). Conversely, the median concentrations of 
arginine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tyrosine, and valine were decreased in 
vcDMEM after 72 h of incubation (Fig. 3). In particular threonine concentrations were rapidly diminished within 
72 h of in vitro culture (half time = 9.23 h). The concentrations of histidine, proline, serine, and tryptophan did 
not change substantially between ccDMEM and vcDMEM during the incubation time (Fig. 3).
Metabolite group Metabolite name Moiety Chemical shift [ppm] (multiplicity*)
Amino acids Alanine β-CH3; α-CH 1.48 (d); 3.79 (q)
Aspartate β-CH2(ii); β-CH2; 2.67 (dd) 2.82 (dd); 3.89 (dd)
Glycine α-CH 3.57 (s)
Isoleucine terminal-CH3/d-CH3; β’-CH3; γ-CH2; γ-CH2; β-CH2; α-CH
0.93 (t); 0.99 (d); 1.26 (m); 1.46 (m); 1.98 (m); 
3.68 (d)
Leucine δ-CH3; δ′-CH3; β-CH2 + γ-CH; α-CH 0.96 (d); 0.97 (d); 1.73 (m); 3.73 (m)
Lysine ε-CH2 3.03 (t)
Methionine β-CH’; δ-CH3; β-CH; γ-CH2 2.12 (m); 2.14 (s); 2.20 (m); 2.65 (t);
Phenylalanine β-CH2’(ii); β-CH2(i); α-CH; 3,5-CH; 2,6-CH; H3
3.13 (dd); 3.29 (dd); 4.00 (dd): 7.34 (m); 7.40 (m); 
7.44 (m)
Threonine γ-CH3; α-CH; β-CH 1.33 (d); 3.59 (d); 4.26 (m)
Tryptophan β-CH2(ii), CH, H5, H5, C2, C7, C4 3.31 (dd), 4.07 (dd), 7.21 (t), 7.29 (t), 7.33 (s), 7.55 (d), 7.74 (d)
Tyrosine β-CH2’; β-CH; CH; 3,5-CH; 2.6-CH 3.06 (dd); 3.20 (dd); 3.95 (dd); 6.91 (m); 7.20 (m)
Valine γ-CH3; γ′-CH3; β-CH2; α-CH 0.99 (d); 1.04 (d); 2.28 (m); 3.62 (d)
Organic acids Acetate CH3 1.93 (s)
Formate CH 8.46 (s)
Fumarate CH 6.52 (s)
Lactate β-CH3; α-CH 1.33 (d); 4.12 (q)
Malate β‘-CH; CH2(ii); α-CH 2.38 (dd); 2.68 (dd); 4.31 (dd)
Succinate 2xCH2 2.40 (s)
Sugars Glucose β-H2; NA; β-H3; α-H2; α-H3; αH5 αH6 αH6; αH5 αH6 αH6; βH6; β-H1; α-H1
3.25 (dd); 3.47 (m); 3.50 (t); 3.54 (dd); 3.72 (t); 
3.78 (dd); 3.84 (c); 3.90 (dd); 4.65 (d); 5.24 (dd);
Myo-inositol CH; 2xCH; 2xCH; CH 3.2912 5CH (t); 3.5458 (dd); 3.6306 (t); 4.0756 (t)
Organic compounds Acetone CH3 2.24 (s)
Ethanol CH3; -CH2 1.19 (t); 3.67 (q)
Table 1. Identified Metabolites in 1H NMR spectra of vcDMEM, ccDMEM, and VF. The table shows metabolite 
group, metabolite name, moiety, and the chemical shift in parts per million (ppm) including the multiplicity 
of identified metabolites for vcDMEM (n = 10), ccDMEM (n = 10), and VF (n = 5). *s, singlet; d, doublets; t, 
triplets; m, multiplets; q, quartet; dd, double doublet.
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Metabolomic comparison between vesicle fluid and culture medium incubated with E. mul-
tilocularis metacestodes. In addition to the culture medium, we analyzed the pool sizes of metabolites 
in VF by 1H-NMR and by quantitative methods. A representative 1D 1H NMR spectrum for VF and analysis of 
metabolite abundance (peak intensities) is given in Supplementary Fig. 1c and Supplementary Table 1. A priori, 
the 1H-NMR-based metabolite profiles cannot be used for a quantitative comparison between culture media and 
VF, as they constitute different biofluids with different TSP values. Nevertheless, as for the culture medium, the 
correlation between the peak integral values obtained by 1H-NMR and by the values obtained by quantitative 
measurements (Fig. 4) was highly significant (Pearson: r = 0.97, p = 2.92 * 10−9). Glucose showed significantly 
lower concentrations in VF than in vcDMEM and threonine was not detectable at all in VF. Conversely, alanine, 
arginine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, serine, tryptophan, tyrosine, 
and valine showed higher concentrations in VF than in vcDMEM. Aspartate, glutamate, lactate, proline, and 
succinate did not significantly differ between vcDMEM and VF (Fig. 4). This difference in metabolite abundance 
and profiles between vcDMEM and VF indicates for selective metabolite transport through the metacestode wall.
Amino acid composition of metacestodes: Is threonine overrepresented in vesicle fluid, in ger-
minal layer cells, or in germinal layer proteins? The fact that threonine as the only amino acid showed 
an unexpectedly high difference between ccDMEM and vcDMEM prompted us to determine the concentrations 
of free amino acids in VF and germinal layer cells, as well as the amino acid composition of the proteome of 
germinal layer cells (Supplementary Fig. 2). We compared the concentration differences for the amino acids with 
lower contents in vcDMEM than in ccDMEM, i.e. consumed metabolites, with their corresponding concentra-
tions in the samples VF, germinal layer cells and germinal layer proteome. All three regressions were significant, 
when threonine – identified by Cook’s distance outlier analysis - was removed (Fig. 5). Taken together, this con-
firms that the high threonine consumption by E. multilocularis metacestodes can neither be explained by protein 
synthesis, nor by storage in germinal layer cells or VF.
Discussion
In the present study, we analyzed the metabolic footprint and requirements of in vitro cultured E. multilocularis 
metacestodes by 1H-NMR, by HPLC and by enzymatic assays to identify essential pathways that may consti-
tute druggable targets. Overall, the results obtained within these independent setups and with three analytical 
methods were in good agreement. Confirming previously published results on protoscoleces48, glucose was the 
metabolite with the highest consumption, and most likely serves as the major energy source for both, metaces-
todes and protoscoleces. Under anaerobic conditions, the energy metabolism of E. multilocularis metacestodes 
is fermentative yielding acetate, alanine, lactate, and succinate as major end products, which accumulate in the 
Metabolite group
Metabolite 
name
OPLS-DA 
discrimination 
score (correlation 
coefficient)
Median integral 
(MAD) for 
vcDMEM
Median integral 
(MAD) for 
ccDMEM
fold change 
of released 
metabolites
fold change 
of consumed 
metabolites
Amino acids Alanine 2.61 (0.99) 215.14 (±15.53) 35.34 (±0.31)* 6.09
Aspartate 0.11 (0.99) 15.67 (±0.61) 2.97 (±0.08)* 5.28
Glycine 1.46 (0.97) 88.22 (±4.60) 59.62 (±0.51) 1.48
Isoleucine −0.25 (−0.81) 71.36 (±0.76) 83.76 (±0.82) 1.17
Leucine −0.47 (−0.96) 110.53 (±1.61) 148.34 (±1.22) 1.34
Lysine 0.01 (0.11) 79.40 (±2.23) 78.72 (±0.64) 1.01
Methionine −0.24 (−0.89) 16.76 (±0.18) 21.95 (±0.27) 1.31
Phenylalanine −0.001* (−0.01) 31.74 (±0.50) 32.37 (±0.31) 1.02
Threonine −0.21 (−0.99) 3.99 (±0.22)* 38.80 (±0.37) 9.72
Tryptophan −0.001 (−0.43) 3.08 (±0.05) 3.25 (±0.06) 1.06
Tyrosine −0.01 (−0.26) 32.32 (±0.30) 33.52 (±0.29) 1.04
Valine −0.28 (−0.81) 89.44 (±0.97) 103.68 (±0.87) 1.16
Organic acids Acetate 23.00 (0.99) 691.00 (±36.56) 91.54 (±1.04) 7.55
Formate 0.16 (0.89) 10.32 (±0.75) 6.21 (±0.08) 1.66
Fumarate 0.37 (0.96) 9.78 (±1.10) 0.29 (±0.05)* 33.72
Lactate 0.32 (0.71) 208.80 (±4.08) 191.41 (±2.26) 1.09
Malate 0.29 (0.96) 23.27 (±3.46) 4.57 (±0.07)* 5.09
Succinate 59.89 (0.99) 1664.01 (±93.71) 4.74 (±0.14)* 351.06
Sugars Glucose −3.28 (−0.98) 1430.80 (±111.80) 2790.20 (±24.25) 1.95
Organic compounds Acetone 0.01 (0.74) 4.31 (±0.13) 3.98 (±0.10) 1.08
Ethanol 0.06 (0.31) 58.76 (±1.12) 53.12 (±0.69) 1.11
Table 2. The metabolic footprint of E. multilocularis metacestodes in vitro. Given are metabolite groups, metabolite 
names, explained differences between vcDMEM/ccDMEM by OPLS-DA (OPLS-DA discrimination score), median 
integrals of metabolite levels in vcDMEM (n = 10) and ccDMEM (n = 10) with the median absolute deviation (MAD) 
in parentheses, and fold changes for released and consumed metabolites. Asterisks indicate not detectable metabolite 
peaks (baseline levels are given).
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culture medium. Glucose was metabolized yielding acetate (26%), alanine (4%), lactate (6%), and succinate (55%, 
see Fig. 6) as end products. The residual 8% of glucose equivalents were not traceable. The generation of succinate 
and acetate – in our study the most abundant end products – is of particular interest. Under anaerobic conditions, 
succinate and acetate are produced in mitochondria by an additional pathway, the malate dismutation pathway. 
Figure 3. Quantitative time-course measurements of acetate, glucose, lactate, succinate, and amino acids in 
vcDMEM and ccDMEM. Metabolite concentrations were determined by (a) enzymatic assays (acetate, glucose, 
lactate, and succinate) and (b) free amino acid quantification by HPLC. Biological triplicates were assessed for 
each timepoint, and median concentrations and ranges are given for each metabolite for the timepoints 0, 2, 6, 
10, 24, 48, and 72 h for vcDMEM and ccDMEM.
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Malate dismutation is found in helminths, marine invertebrates, and euglenids57–59. This pathway can be consid-
ered as a partial inversion or a shunt of the citric acid cycle. All knowledge on this pathway in helminths is based 
on nematodes (Ascaris suum and filaria), trematodes (Schistosoma mansoni and Fasciola hepatica) as well as the 
cestode Hymenolepis diminuta58. Under anaerobic conditions, pyruvate is imported into the mitochondria, but not 
decarboxylated via pyruvate dehydrogenase. Rather, it is carboxylated to oxaloacetate via pyruvate carboxylase. 
The reduction of oxaloacetate to malate, the conversion of malate to fumarate and the reduction of fumarate to 
succinate is performed by the corresponding enzymes of the citrate cycle working in the reverse direction, thereby 
regenerating NAD from NADH. The reduction of fumarate to succinate is dependent on complexes I and II of 
the mitochondrial respiratory chain. Complex I transfers electrons from NADH to rhodoquinone, an electron 
carrier with a much lower redox potential than the mammalian carrier ubiquinone. Rhodoquinone transfers 
these electrons to complex II which operates in the opposite direction than in oxidative phosphorylation, namely 
as a fumarate reductase instead of succinate dehydrogenase58,59. Succinate as a final product of this fermentative 
pathway is then excreted to the medium (see Fig. 6 for an overview). Some parasitic helminths further metabolize 
succinate to propionate or volatile fatty acids. So far, there is no indication that these reactions also take place 
in Echinococcus, as these metabolites have never been detected in the parasite, nor are the responsible enzymes 
identified in the Echinococcus genomes. Thus, for helminths, malate dismutation is an important pathway to 
eliminate redox equivalents under anaerobic conditions. By generating a proton gradient via complex I, it may 
even contribute to mitochondrial ATP synthesis59,60. To date, Echinococcus species were largely excluded from 
studies of the malate dismutation pathway, even though accumulation of succinate was described early, mostly 
in E. granulosus protoscoleces47,61,62 and cysts37, but also in E. multilocularis protoscoleces47 and metacestodes63. 
Absent in mammalian cells, malate dismutation may constitute a highly interesting drug target, which has been 
addressed in one study that investigated this pathway in protoscoleces of E. multilocularis64. Moreover, the high 
release of metabolic end products could modulate the host response, as it was shown that succinate and fumarate 
can induce host cell apoptosis65, and succinate stimulates IL-1β secretion in T-cells and could therefore cause 
inflammation66.
Figure 4. Concentrations of amino acids and selected metabolites in vcDMEM and VF. (a) Quantitative 
enzymatic assays of acetate, glucose, lactate, and succinate and (b) free amino acid quantification by HPLC 
were applied to measure metabolite concentrations in the samples vcDMEM and VF. Metabolite concentrations 
from three biological replicates are depicted as median and range in mM for the 72 h timepoint. The numbers 
above each bar pair represent Bonferroni adjusted p values derived from two sample two-sided T-test with a 
significance level of α = 0.05. ND = not detected.
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Figure 5. Free amino acid concentrations in vesicle fluid, in germinal layer cells, and germinal layer cell 
proteins. Amino acid uptake by E. multilocularis metacestodes (y-axis) was identified by the difference in amino 
acid concentrations in vcDMEM (n = 3) and ccDMEM (n = 3) as measured by HPLC. Amino acid consumption 
is depicted in relation to (a) free amino acids in VF (n = 3, x-axis), (b) free amino acids in germinal layer cells 
(n = 3, x-axis), and (c) amino acid composition of germinal layer cell proteins (n = 3, x-axis) as analyzed by 
HPLC. Median values in mM are depicted. The respective linear regressions are given excluding threonine. P 
values were determined by F-test.
Figure 6. Overview of the mitochondrial energy metabolism and released and consumed metabolites by E. 
multilocularis metacestodes in vitro. The mitochondrial energy metabolism of E. multilocularis is given based on 
information from previous studies32,33,47,48,62,75. Aerobic pathways are given in purple, anaerobic ones in blue. Outside 
the mitochondrial membrane (black lines), glycolysis (G) and fermentation pathways (F, alanine, ethanol, and lactic) 
are depicted. Inside the mitochondrial membrane, malate dismutation (MD), rhodoquinone (RQ), tricarboxylic 
acid cycle (TCA), and ubiquinone (UQ) are given. Metabolites consumed in vitro by E. multilocularis metacestodes, 
as found within this study, are depicted in yellow, released ones in green. Metabolites that were released more than 
five times are indicated with bold letters and a rectangle (acetate, alanine, fumarate, malate, succinate; aspartate is not 
depicted). The pathways for consumed metabolites need to be further investigated. Putative pathways for use in the 
energy metabolism were determined in KEGG (indicated by asterisks)76. The most strongly consumed metabolites 
are indicated with bold letters and a rectangle (glucose and threonine). Percentages of these metabolites as produced 
from consumed glucose equivalents are given.
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The second most abundant fermentation product of metacestodes detected in this study is acetate which 
confirms the results described for E. multilocularis protoscoleces47. The generation of acetate as fermentative end 
product may be a consequence of the malate dismutation pathway which shunts the citrate cycle (see above). 
Lacking oxaloacetate as acceptor, acetyl-CoA resulting from imported pyruvate or from lipid degradation67,68 
transiently accumulates and is hydrolyzed to acetate, thereby regenerating coenzyme A. Acetate is then secreted.
The third major fermentation end product, alanine, is generated from pyruvate by transamination in the cyto-
sol. Conversely, pool sizes of lactate, the classical fermentation end product in mammalian cells, do not markedly 
differ between the three fluids investigated in this study.
The difference in abundance, but not spectrum, of metabolites between vcDMEM and VF could be explained 
by the fact that small metabolites (alanine, arginine, glycine, histidine, isoleucine, leucine, lysine, methionine, 
phenylalanine, serine, tryptophan, tyrosine, and valine) pass the metacestode wall but are selectively accumu-
lated inside. Myo-inositol was detected in traces in VF, not in vcDMEM, but no further focus was laid on this 
metabolite in the present study. Overall, our results on VF composition are in agreement with previous studies 
on the composition of E. granulosus ex vivo hydatid fluid34,37,38,41. The only difference is that in E. multilocularis 
metacestode VF, alanine is the most abundant amino acid whereas in hydatid fluid, glycine is the most abundant 
amino acid34,41,69. E. multilocularis releases traces of aspartate, glutamate, and glycine into the medium. Thus, 
we consider that in addition to alanine, these three amino acids can be synthesized by E. multilocularis. Based 
on transcriptomic information, the synthesis pathways for all other amino acids are incomplete or lacking32. 
Therefore, they have to be taken up from the culture medium. Most striking is the almost complete exhaustion 
of the threonine pool (0.67 mM) from the culture medium. This confirms a previous study where threonine was, 
amongst other metabolites, taken up by E. granulosus metacestodes40, but this effect was not further investigated. 
The mucin-type glycoprotein Em2, synthesized in germinal layer cells and a major antigen of the laminated 
layer, is known to be rich in threonine and proline70. However, we could not detect any overuse of threonine 
for protein synthesis. Therefore, Em2 production cannot be the main cause of the high consumption of threo-
nine by E. multilocularis metacestodes. Interestingly, threonine is known to be the only amino acid absolutely 
essential for the rapid division of mouse embryonic stem cells71. Threonine is hereby converted by threonine 
dehydrogenase and 2-amino-3-ketobutyrate coenzyme A ligase into glycine and acetyl-CoA, two metabolites 
that are then further used for purine synthesis and DNA-replication, and energy generation, respectively71. In the 
procyclic (insect stage) form of African trypanosomes, threonine is also converted via threonine dehydrogenase 
and 2-amino-3-ketobutyrate coenzyme A ligase, but finally feeding into fatty acid synthesis72–74. Whether the 
respective pathways are present and active in E. multilocularis should be further investigated. The release of gly-
cine within our in vitro setup is in favor of according pathways being active. Other consumed amino acids, such 
as isoleucine, leucine, methionine, and valine, could also be metabolized into mitochondrial energy-generating 
pathways (Fig. 6). Glutamine was not detected by the methods used here, because the media used contained an 
altered, stabilized form of glutamine.
Taken together, this is the first characterization of the in vitro metabolomic footprint of E. multilocularis meta-
cestodes and the respective composition of VF. The predominance of malate dismutation and the consumption of 
the amino acid threonine in E. multilocularis metacestodes in vitro lay the basis for further studies on potentially 
targetable pathways for targeting this most deadly of all helminth diseases.
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